Gastroparesis and Parkinson’s disease: a systematic review

Staging of brain pathology related to sporadic Parkinson’s disease

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · see citing works

Gastrointestinal dysfunction in Parkinson's disease

Pfeiffer, R. F. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00307-7 · Cited by 925 · see citing works

Where Does Parkinson Disease Pathology Begin in the Brain?

Del Tredici, K., Rüb, U., de Vos, R. A. I., Bohl, J. R. E., & Braak, H. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.5.413 · Cited by 773 · see citing works

Demography, Clinical Characteristics, Psychological and Abuse Profiles, Treatment, and Long-Term Follow-up of Patients with Gastroparesis

Soykan, I., Sivri, B., Sarosiek, I., Kiernan, B., & Mccallum, R. W. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1026665728213 · Cited by 575 · see citing works

Gastric electrical stimulation for medically refractory gastroparesis

Abell, T. L., McCallum, R. W., Hocking, M. P., Koch, K. L., Abrahamsson, H., Leblanc, I., Lindberg, G., Konturek, J. W., Nowak, T. V., Quigley, E. M. M., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00878-3 · Cited by 563 · see citing works

Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses

Wakabayashi, K., Takahashi, H., Takeda, S., Ohama, E., & Ikuta, F. (1988) · Acta Neuropathologica · doi:10.1007/bf00687767 · Cited by 528 · see citing works

Gastric pacing improves emptying and symptoms in patients with gastroparesis

McCallum, R. W., Chen, J. D. Z., Lin, Z., Schirmer, B. D., Williams, R. D., & Ross, R. A. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70528-1 · Cited by 415 · see citing works

Development and validation of a patient‐assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index

Revicki, D. A., Rentz, A. M., Dubois, D., Kahrilas, P. J., Stanghellini, V., Talley, N. J., & Tack, J. F. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01612.x · Cited by 380 · see citing works

Gastrointestinal symptoms in Parkinson's disease

Edwards, L. L., Pfeiffer, R. F., Quigley, E. M. M., Hofman, R., & Balluff, M. (1991) · Movement Disorders · doi:10.1002/mds.870060211 · Cited by 373 · see citing works

Clinical Features of Idiopathic Gastroparesis Vary With Sex, Body Mass, Symptom Onset, Delay in Gastric Emptying, and Gastroparesis Severity

Parkman, H. P., Yates, K. P., Hasler, W. L., Nguyen, L. A. B., Pasricha, P. J., Snape, W. J., Farrugia, G., Koch, K. L., Abell, T. L., McCallum, R. W., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.10.015 · Cited by 348 · see citing works

Functional dyspepsia, delayed gastric emptying, and impaired quality of life

Talley, N. J., Locke, G. R., Lahr, B. D., Zinsmeister, A. R., Tougas, G., Ligozio, G., Rojavin, M. A., & Tack, J. F. (2005) · Gut · doi:10.1136/gut.2005.078634 · Cited by 283 · see citing works

A Placebo-Controlled Trial of Itopride in Functional Dyspepsia

Holtmann, G., Talley, N. J., Liebregts, T., Adam, B., & Parow, C. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052639 · Cited by 256 · see citing works

Gastric emptying time and gastric motility in patients with Parkinson's disease

Hardoff, R., Sula, M., Tamir, A., Soil, A., Front, A., Badarna, S., Honigman, S., & Giladi, N. (2001) · Movement Disorders · doi:10.1002/mds.1203 · Cited by 248 · see citing works

Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease

ANDERSON, G., Noorian, A. R., Taylor, G. T., Anitha, M., BERNHARD, D., SRINIVASAN, S., & GREENE, J. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.05.010 · Cited by 238 · see citing works

Gastrointestinal dysfunction in Parkinson's disease

Edwards, L., Quigley, E., & Pfeiffer, R. (1992) · Neurology · doi:10.1212/wnl.42.4.726 · Cited by 226 · see citing works

<i>Helicobacter pylori</i> eradication and l-dopa absorption in patients with PD and motor fluctuations

Pierantozzi, M., Pietroiusti, A., Brusa, L., Galati, S., Stefani, A., Lunardi, G., Fedele, E., Sancesario, G., Bernardi, G., Bergamaschi, A., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000221672.01272.ba · Cited by 199 · see citing works

Autonomic dysfunction in Parkinson's disease: a comprehensive symptom survey

Siddiqui, M. F., Rast, S. A., Lynn, M., Auchus, A. P., & Pfeiffer, R. F. (2002) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(01)00052-9 · Cited by 195 · see citing works

A placebo-controlled trial of itopride in functional dyspepsia.

Piche, T. (2006) · Hépato-Gastro & Oncologie Digestive · Cited by 190 · see citing works

Gastric emptying in Parkinson's disease

Djaldetti, R., Baron, J., Ziv, I., & Melamed, E. (1996) · Neurology · doi:10.1212/wnl.46.4.1051 · Cited by 189 · see citing works

Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials

Talley, N. J., Tack, J. F., Ptak, T., Gupta, R., & Giguère, M. (2007) · Gut · doi:10.1136/gut.2007.132449 · Cited by 182 · see citing works

Gastrointestinal Motility Problems in Patients with Parkinsonʼs Disease

Jost, W. H. (1997) · Drugs & Aging · doi:10.2165/00002512-199710040-00002 · Cited by 178 · see citing works

Erratic gastric emptying of levodopa may cause “random” fluctuations of parkinsonian mobility

Kurlan, R., Rothfield, K. P., Woodward, W. R., Nutt, J. G., Miller, C., Lichter, D. G., & Shoulson, I. (1988) · Neurology · doi:10.1212/wnl.38.3.419 · Cited by 168 · see citing works

Scintigraphic evaluation of gastric emptying

Malmud, L. S., Fisher, R. S., KNIGHT, L. C., & Rock, E. (1982) · Seminars in Nuclear Medicine · doi:10.1016/s0001-2998(82)80003-2 · Cited by 167 · see citing works

Gastric Emptying Rate in the Elderly: Implications for Drug Therapy

Evans, M. A., Triggs, E., Cheung, M. O., Broe, G., & Creasey, H. (1981) · Journal of The American Geriatrics Society · doi:10.1111/j.1532-5415.1981.tb01766.x · Cited by 166 · see citing works

Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with parkinson's disease

Soykan, İ., Sarosiek, I., Shifflett, J., Wooten, G. F., & McCallum, R. W. (1997) · Movement Disorders · doi:10.1002/mds.870120618 · Cited by 163 · see citing works

Involvement of vagal autonomic nuclei in multiple system atrophy and Lewy body disease

Benarroch, E. E., Schmeichel, A. M., Sandroni, P., Low, P. A., & Parisi, J. E. (2006) · Neurology · doi:10.1212/01.wnl.0000196638.98781.bb · Cited by 146 · see citing works

Predictors of gastric emptying in Parkinson's disease

Goetze, O., Nikodem, A., Wiezcorek, J., Banasch, M., Przuntek, H., Mueller, T. J., Schmidt, W. E., & Woitalla, D. (2006) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00780.x · Cited by 146 · see citing works

Impact of Gastric Emptying on Levodopa Pharmacokinetics in Parkinson Disease Patients

M�ller, T., Erdmann, C., Bremen, D., Schmidt, W. E., Muhlack, S., Woitalla, D., & Goetze, O. (2006) · Clinical Neuropharmacology · doi:10.1097/00002826-200603000-00001 · Cited by 131 · see citing works

Effect of age on gastric emptying of liquid-solid meals in man

Moore, J. G., Tweedy, C., Christian, P., & Datz, F. (1983) · Digestive Diseases and Sciences · doi:10.1007/bf01324951 · Cited by 125 · see citing works

Impaired gastric emptying of a solid test meal in patients with Parkinson's disease using 13C-sodium octanoate breath test

Goetze, O., Wieczorek, J., Mueller, T. J., Przuntek, H., Schmidt, W. E., & Woitalla, D. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.11.007 · Cited by 116 · see citing works

GASTRIC AND SMALL INTESTINAL MOTILITY IN HEALTH AND DISEASE

Quigley, E. M. M. (1996) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70368-x · Cited by 112 · see citing works

Episodic unresponsiveness to single doses of L‐dopa in parkinsonian fluctuators

Melamed, E., Bitton, V., & Zelig, O. (1986) · Neurology · doi:10.1212/wnl.36.1.100 · Cited by 90 · see citing works

Neurochemical plasticity in the enteric nervous system of a primate animal model of experimental Parkinsonism

Chaumette, T., Lebouvier, T., Aubert, P., Lardeux, B., Qin, C., Li, Q., Accary, D., Bézard, E., Varannes, S. B. D., Derkinderen, P., et al. (2009) · Neurogastroenterology and Motility · doi:10.1111/j.1365-2982.2008.01226.x · Cited by 86 · see citing works

Reduced L -dopa absorption and increased clinical fluctuations in Helicobacter pylori -infected Parkinson's disease patients

Pierantozzi, M., Pietroiusti, A., Sancesario, G., Lunardi, G., Fedele, E., Giacomini, P., Frasca, S., Galante, A., Marciani, M. G., & Stanzione, P. (2001) · Neurological Sciences · doi:10.1007/s100720170061 · Cited by 85 · see citing works

A Systematic Review on Intrapyloric Botulinum Toxin Injection for Gastroparesis

Bai, Y., Xu, M., Yang, X., Xu, C., Gao, J., Zou, D., & Li, Z. (2009) · Digestion · doi:10.1159/000235917 · Cited by 83 · see citing works

Role of Chronic Infection and Inflammation in the Gastrointestinal Tract in the Etiology and Pathogenesis of Idiopathic Parkinsonism

Dobbs, R. J., Dobbs, S. M., Weller, C., Bjarnason, I., Oxlade, N. L., Charlett, A., Al-Janabi, M., Kerwin, R. W., Mahler, R. F., & Price, A. B. (2005) · Helicobacter · doi:10.1111/j.1523-5378.2005.00331.x · Cited by 79 · see citing works

In-vitro interaction of L-dopa with bacterial adhesins of Helicobacter pylori: an explanation for clinicial differences in bioavailability?

Niehues, M., & Hensel, A. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.61.10.0005 · Cited by 77 · see citing works

Is there a delayed gastric emptying of patients with early-stage, untreated Parkinson’s disease? An analysis using the 13C-acetate breath test

Tanaka, Y., Kato, T., Nishida, H., Yamada, M., Koumura, A., Sakurai, T., Hayashi, Y., Kimura, A., Hozumi, I., Araki, H., et al. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5769-z · Cited by 73 · see citing works

Increased gastric motility during 5-HT4 agonist therapy reduces response fluctuations in Parkinson's disease

Asai, H., Udaka, F., Hirano, M., Minami, T., Oda, M., Kubori, T., Nishinaka, K., Kameyama, M., & Ueno, S. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.06.007 · Cited by 71 · see citing works

Gastrointestinal Dysfunction in Parkinson???s Disease

Byrne, K. G., Pfeiffer, R. F., & Quigley, E. M. M. (1994) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199407000-00004 · Cited by 70 · see citing works

Efficacy of Prolonged Administration of Intravenous Erythromycin in an Ambulatory Setting as Treatment of Severe Gastroparesis: One Center's Experience

DiBaise, J. K., & Quigley, E. M. M. (1999) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199903000-00009 · Cited by 63 · see citing works

Role of Chronic Infection and Inflammation in the Gastrointestinal Tract in the Etiology and Pathogenesis of Idiopathic Parkinsonism

Bjarnason, I., Charlett, A., Dobbs, R. J., Dobbs, S. M., Ibrahim, M. A. A., Kerwin, R. W., Mahler, R. F., Oxlade, N. L., Peterson, D. W., Plant, J., et al. (2005) · Helicobacter · doi:10.1111/j.1523-5378.2005.00330.x · Cited by 62 · see citing works

Gastric emptying after semi–solid food in multiple system atrophy and Parkinson disease

Thomaides, T., Karapanayiotides, T., Zoukos, Y., Haeropoulos, C., Kerezoudi, E., Demacopoulos, N., Floodas, G., Papageorgiou, E., Armakola, F., Thomopoulos, Y., et al. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0815-y · Cited by 60 · see citing works

The role of continuous subcutaneous insulin infusion therapy in patients with diabetic gastroparesis

Sharma, D., Morrison, G., Joseph, F., Purewal, T. S., & Weston, P. J. (2011) · Diabetologia · doi:10.1007/s00125-011-2282-6 · Cited by 53 · see citing works

Gastrointestinal Dysfunction in Neurologic Disease

Camilleri, M., & Bharucha, A. (1996) · Seminars in neurology · doi:10.1055/s-2008-1040977 · Cited by 51 · see citing works

Selection Criteria for Preoperative Endoscopic Retrograde Cholangiopancreatography in the Laparoscopic Era

Robertson, G. S. M. (1996) · Archives of Surgery · doi:10.1001/archsurg.1996.01430130091019 · Cited by 48 · see citing works

Evaluation of gastric emptying in familial and sporadic Parkinson disease

Krygowska‐Wajs, A., Cheshire, W. P., Wszołek, Z. K., Hubalewska–Dydejczyk, A., Jasińska‐Myga, B., Farrer, M. J., Moskała, M. M., & Sowa‐Staszczak, A. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.04.003 · Cited by 45 · see citing works

Two‐channel gastric pacing in patients with diabetic gastroparesis

Lin, Z., Sarosiek, I., Forster, J., Ross, R. A., Chen, J. D. Z., & McCallum, R. W. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2011.01754.x · Cited by 44 · see citing works

Gastric Myoelectrical Activity in Patients with Parkinson's Disease (Evidence of a Primary Gastric Abnormality)

Soykan, İ., Lin, Z., Bennett, J. P., & McCallum, R. W. (1999) · Digestive Diseases and Sciences · doi:10.1023/a:1026648311646 · Cited by 40 · see citing works

Botulinum toxin type A for the treatment of gastroparesis in Parkinson’s disease patients

Gil, R. A., Hwynn, N., Fabian, T., Joseph, S., & Fernandez, H. H. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.01.007 · Cited by 35 · see citing works

Distribution of dopamine-containing neurons and fibres in the feline medulla oblongata: A comparative study using catecholaminesynthesizing enzyme and dopamine immunohistochemistry

Maqbool, A., Batten, T. F. C., Berry, P., & McWilliam, P. N. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90619-q · Cited by 33 · see citing works

Oral solution of levodopa ethylester for treatment of response fluctuations in patients with advanced Parkinson's disease

Djaldetti, R., Inzelberg, R., Giladi, N., Korczyn, A. D., Peretz-Aharon, Y., Rabey, M. J., Herishano, Y., Honigman, S., Badarny, S., & Melamed, E. (2002) · Movement Disorders · doi:10.1002/mds.10075 · Cited by 32 · see citing works

Gastrointestinal Motility Problems in Patients with Parkinson???s Disease

Pfeiffer, R. F., & Quigley, E. M. M. (1999) · CNS Drugs · doi:10.2165/00023210-199911060-00003 · Cited by 31 · see citing works

Circadian Rhythmicity in Levodopa Pharmacokinetics in Patients With Parkinson Disease

Nyholm, D., Lennernäs, H., Johansson, A., Estrada, M., & Aquilonius, S. (2010) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181e70f7a · Cited by 29 · see citing works

Predictors of gastroparesis in out-patients with secondary and idiopathic upper gastrointestinal symptoms

Stanghellini, V., Tosetti, C., Horowitz, M., GIORGIO, R. D., Barbara, G., Cogliandro, R. F., Cogliandro, L., & Corinaldesi, R. (2003) · Digestive and Liver Disease · doi:10.1016/s1590-8658(03)00164-6 · Cited by 29 · see citing works

Electrogastrography in Patients with Parkinson’s Disease

Naftali, T., Gadoth, N., Huberman, M., & Novis, B. (2005) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100016929 · Cited by 24 · see citing works

Is there a difference in gastric emptying between Parkinson’s disease patients under long-term l-dopa therapy with and without motor fluctuations? An analysis using the 13C-acetate breath test

Tanaka, Y., Kato, T., Nishida, H., Araki, H., Murase, M., Nagaki, M., Moriwaki, H., & Inuzuka, T. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5220-5 · Cited by 23 · see citing works

Impaired Gastric Myoelectrical Activity in Patients with Parkinson's Disease and Effect of Levodopa Treatment

Lu, C., Shan, D., Chen, C., Luo, J., Chang, F.-Y., Lee, S., Wu, H., & Chen, J. D. Z. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000030083.50003.07 · Cited by 23 · see citing works

Gastric myoelectrical differences between Parkinson's disease and multiple system atrophy

Sakakibara, Y., Asahina, M., Suzuki, A., & Hattori, T. (2009) · Movement Disorders · doi:10.1002/mds.22265 · Cited by 22 · see citing works

Gastric electromechanical dysfunction in Parkinson's disease.

Krygowska‐Wajs, A., Lorens, K., Thor, P., Szczudlik, A., & Konturek, S. J. (2000) · PubMed · Cited by 22 · see citing works

Peripheral mechanisms of intestinal dysmotility in rats with salsolinol induced experimental Parkinson's disease.

Banach, T., Zurowski, D., Gil, K., Krygowska‐Wajs, A., Marszałek, A., & Thor, P. J. (2006) · PubMed · Cited by 22 · see citing works

Utility of Electrogastrography in Differentiating Parkinson’s Disease with or without Gastrointestinal Symptoms: A Prospective Controlled Study

Chen, C., Lin, H.-H., Chen, S.-Y., & Lin, S. (2005) · Digestion · doi:10.1159/000086143 · Cited by 20 · see citing works

Continuous dopaminergic delivery in Parkinson’s disease

Antonini, A., Ursino, G., Calandrella, D., Bernardi, L., & Plebani, M. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5714-1 · Cited by 19 · see citing works

Pharmacokinetics of Etilevodopa Compared to Levodopa in Patient's With Parkinson's Disease: An Open-label, Randomized, Crossover Study

Djaldetti, R., Giladi, N., Hassin‐Baer, S., Shabtai, H., & Melamed, E. (2003) · Clinical Neuropharmacology · doi:10.1097/00002826-200311000-00012 · Cited by 18 · see citing works

Pharmacotherapy of gastroparesis

Quigley, E. M. M. (2000) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.1.5.881 · Cited by 17 · see citing works

The Incidence, Prevalence, and Survival of Gastroparesis in Olmsted County, Minnesota, 1996-2006 (Gastroenterology 2009;136:1225-1233)

Jung, H. (2010) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2010.16.1.99 · Cited by 14 · see citing works

Effects of slowed gastrointestinal motility on levodopa pharmacokinetics

Fernández, N., Garcia, J. J., Diez, M. J., Sahagún, A. M., González, A., Díez, R., & Sierra, M. (2010) · Autonomic Neuroscience · doi:10.1016/j.autneu.2010.03.016 · Cited by 8 · see citing works

Effects of Plantago ovata Husk on Levodopa (with Carbidopa) Bioavailability in Rabbits with Autonomic Gastrointestinal Disorders

Garcia, J. J., Fernández, N., Calle, Á. P., Diez, M. J., Sahagún, A. M., & Sierra, M. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.026229 · Cited by 8 · see citing works

Gastric electrical stimulation: a report of two cases.

Sibartie, V., Quigley, E. M. M., O'Donnell, A., O’Halloran, D., & Thompson, C. (2005) · PubMed · Cited by 1 · see citing works

Gastrointestinal Dysfunction in Parkinson’s Disease

Fasano, A., Visanji, N. P., Liu, L. W. C., Lang, A. E., & Pfeiffer, R. F. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00007-1 · Cited by 1,016 · see citing works

Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features

Li, W., Wu, X., Hu, X., Wang, T., Liang, S., Duan, Y., Jin, F., & Qin, B. (2017) · Science China Life Sciences · doi:10.1007/s11427-016-9001-4 · Cited by 406 · see citing works

Weight Loss and Malnutrition in Patients with Parkinson's Disease: Current Knowledge and Future Prospects

Ma, K., Xiong, N., Shen, Y., Han, C., Liu, L., Zhang, G., Wang, L., Guo, S., Guo, X., Xia, Y. F., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00001 · Cited by 379 · see citing works

Autonomic dysfunction in Parkinson’s disease: Implications for pathophysiology, diagnosis, and treatment

Chen, Z., Li, G., & Liu, J. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104700 · Cited by 364 · see citing works

Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics: An UNGAP review

Vinarov, Z., Abdallah, M., Agúndez, J. A. G., Allegaert, K., Basit, A. W., Braeckmans, M., Ceulemans, J., Corsetti, M., Griffin, B. T., Grimm, M. F., et al. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.105812 · Cited by 380 · see citing works

Gastrointestinal manifestations in Parkinson's disease: Prevalence and occurrence before motor symptoms

Cersosimo, M. G., Raina, G. B., Pecci, C., Pellene, A., Calandra, C. R., Gutiérrez, C., Micheli, F. E., & Benarroch, E. E. (2013) · Journal of Neurology · doi:10.1007/s00415-012-6801-2 · Cited by 314 · see citing works

Gastrointestinal motility disorders in neurologic disease

Camilleri, M. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143771 · Cited by 211 · see citing works

Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms

Felice, V. D., Quigley, E. M., Sullivan, A. M., O'Keeffe, G. W., & O'Mahony, S. M. (2016) · Parkinsonism &amp; Related Disorders · doi:10.1016/j.parkreldis.2016.03.012 · Cited by 205 · see citing works

Gastrointestinal involvement in Parkinson’s disease: pathophysiology, diagnosis, and management

Warnecke, T., Schäfer, K., Claus, I., Tredici, K. D., & Jost, W. H. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00295-x · Cited by 189 · see citing works

Delayed gastric emptying in Parkinson's disease

Marrinan, S. L., Emmanuel, A. V., & Burn, D. J. (2013) · Movement Disorders · doi:10.1002/mds.25708 · Cited by 157 · see citing works

Gut dysfunction in Parkinson's disease

Mukherjee, A., Biswas, A., & Das, S. K. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i25.5742 · Cited by 156 · see citing works

Gastrointestinal Dysfunctions in Parkinson’s Disease: Symptoms and Treatments

Poirier, A.-A., Aubé, B., Côté, M., Morin, N., Di Paolo, T., & Soulet, D. (2016) · Parkinson s Disease · doi:10.1155/2016/6762528 · Cited by 130 · see citing works

Unmasking levodopa resistance in Parkinson's disease

Nonnekes, J. H., Timmer, M. H. M., de Vries, N. M., Rascol, O., Helmich, R. C. G., & Bloem, B. R. (2016) · Movement Disorders · doi:10.1002/mds.26712 · Cited by 125 · see citing works

Rotenone induces gastrointestinal pathology and microbiota alterations in a rat model of Parkinson’s disease

Johnson, M. E., Stringer, A., & Bobrovskaya, L. (2018) · NeuroToxicology · doi:10.1016/j.neuro.2018.02.013 · Cited by 122 · see citing works

Mice overexpressing wild‐type human alpha‐synuclein display alterations in colonic myenteric ganglia and defecation

Wang, L., Magen, I., Yuan, P. Q., Subramaniam, S., Richter, F., Chesselet, M. ‐., & Taché, Y. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01974.x · Cited by 115 · see citing works

Mechanisms of Body Weight Fluctuations in Parkinson’s Disease

Kistner, A., Lhommée, E., & Krack, P. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00084 · Cited by 114 · see citing works

Autonomic Dysfunction in Parkinson's Disease

Pfeiffer, R. F. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00897-4 · Cited by 112 · see citing works

Altered Gut Microbiome and Intestinal Pathology in Parkinson’s Disease

Chiang, H., & Lin, C. (2019) · Journal of Movement Disorders · doi:10.14802/jmd.18067 · Cited by 104 · see citing works

Neurodegenerative disorders and gut-brain interactions

Singh, A., Dawson, T. M., & Kulkarni, S. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143775 · Cited by 102 · see citing works

The dynamic gastric environment and its impact on drug and formulation behaviour

Abeele, J. V. D., Rubbens, J., Brouwers, J., & Augustijns, P. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.08.060 · Cited by 102 · see citing works

Artifact Rejection Methodology Enables Continuous, Noninvasive Measurement of Gastric Myoelectric Activity in Ambulatory Subjects

Gharibans, A. A., Smarr, B. L., Kunkel, D. C., Kriegsfeld, L. J., Mousa, H. M., & Coleman, T. P. (2018) · Scientific Reports · doi:10.1038/s41598-018-23302-9 · Cited by 100 · see citing works

Gastrointestinal Dysfunction in Parkinson’s Disease

Pfeiffer, R. F. (2018) · Current Treatment Options in Neurology · doi:10.1007/s11940-018-0539-9 · Cited by 94 · see citing works

The gut-brain axis and Parkinson disease: Clinical and pathogenetic relevance

Menozzi, E., Macnaughtan, J., & Schapira, A. H. V. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1890330 · Cited by 81 · see citing works

Apomorphine Subcutaneous Injection for the Management of Morning Akinesia in Parkinson's Disease

Isaacson, S., Lew, M., Ondo, W. G., Hubble, J. P., Clinch, T., & Pagán, F. (2016) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12350 · Cited by 81 · see citing works

The role of the vagal pathway and gastric dopamine in the gastroparesis of rats after a 6‐hydroxydopamine microinjection in the substantia nigra

Zheng, L., Song, J., Fan, R. ‐., Chen, C. ‐., Ren, Q. ‐., Zhang, X. ‐., Feng, X., Zhang, Y., Li, L. ‐., & Zhu, J. (2014) · Acta Physiologica · doi:10.1111/apha.12229 · Cited by 80 · see citing works

The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson’s disease

Barboza, J., Okun, M. S., & Moshiree, B. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1086747 · Cited by 78 · see citing works

Ghrelin and Neurodegenerative Disorders—a Review

Shi, L.-M., Du, X.-X., Jiang, H., & Xie, J.-X. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9729-1 · Cited by 73 · see citing works

Gastric motor dysfunctions in Parkinson's disease: Current pre-clinical evidence

Pellegrini, C., Antonioli, L., Colucci, R., Ballabeni, V., Barocelli, E., Bernardini, N., Blandizzi, C., & Fornai, M. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.10.011 · Cited by 73 · see citing works

Clinical implications of gastric complications on levodopa treatment in Parkinson’s disease

Pfeiffer, R. F., Isaacson, S. H., & Pahwa, R. (2020) · Parkinsonism &amp; Related Disorders · doi:10.1016/j.parkreldis.2020.05.001 · Cited by 77 · see citing works

Pathophysiology of non-motor signs in Parkinson’s disease: some recent updating with brief presentation

Radad, K., Moldzio, R., Krewenka, C., Kranner, B., & Rausch, W. (2023) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2023.00036 · Cited by 68 · see citing works

Gastrointestinal syndromes preceding a diagnosis of Parkinson’s disease: testing Braak’s hypothesis using a nationwide database for comparison with Alzheimer’s disease and cerebrovascular diseases

Konings, B., Villatoro, L. G., den Eynde, J. V., Barahona, G. A., Burns, R., McKnight, M., Hui, K. Y., Yenokyan, G., Tack, J. F., & Pasricha, P. J. (2023) · Gut · doi:10.1136/gutjnl-2023-329685 · Cited by 65 · see citing works

Parkinson’s Disease and the Gut: Symptoms, Nutrition, and Microbiota

Yemula, N., Dietrich, C. M., Dostal, V., & Hornberger, M. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212707 · Cited by 63 · see citing works

Safety and Tolerability of Pharmacotherapies for Parkinson’s Disease in Geriatric Patients

Klietz, M., Greten, S., Wegner, F., & Höglinger, G. U. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00654-z · Cited by 62 · see citing works

Pharmacokinetics of Rytary®, An Extended-Release Capsule Formulation of Carbidopa–Levodopa

Mittur, A. V., Gupta, S., & Modi, N. B. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0511-y · Cited by 60 · see citing works

New ghrelin agonist, HM01 alleviates constipation and L-dopa-delayed gastric emptying in 6-hydroxydopamine rat model of Parkinson’s disease

Karasawa, H., Pietra, C., Giuliano, C., García-Rubio, S., Xu, X., Yakabi, S., Taché, Y., & Wang, L.-X. (2014) · Neurogastroenterology and Motility · doi:10.1111/nmo.12459 · Cited by 62 · see citing works

The Beneficial Role of Thiamine in Parkinson Disease

Lương, K. V. Q., & Nguyễn, L. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12078 · Cited by 57 · see citing works

Physiology of the ageing gut

Rayner, C., & Horowitz, M. (2013) · Current opinion in clinical nutrition and metabolic care · doi:10.1097/mco.0b013e32835acaf4 · Cited by 54 · see citing works

Gastric emptying in Parkinson's disease – A mini-review

Knudsen, K., Szwebs, M., Hansen, A. K., & Borghammer, P. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.06.003 · Cited by 49 · see citing works

MitoPark transgenic mouse model recapitulates the gastrointestinal dysfunction and gut-microbiome changes of Parkinson’s disease

Ghaisas, S., Langley, M. R., Palanisamy, B. N., Dutta, S., Kirthi, N., Plummer, P. J., Sarkar, S., Ay, M., Jin, H., Anantharam, V., et al. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.09.004 · Cited by 49 · see citing works

Gastroparesis in Parkinson Disease: Pathophysiology, and Clinical Management

Soliman, H., Coffin, B., & Gourcerol, G. (2021) · Brain Sciences · doi:10.3390/brainsci11070831 · Cited by 52 · see citing works

Delayed Gastric Emptying in Advanced Parkinson Disease

BESTETTI, A., Capozza, A., Lacerenza, M. R., Manfredi, L., & Mancini, F. (2016) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001470 · Cited by 48 · see citing works

Autonomic dysfunction in Parkinson disease and animal models

Metzger, J. M., & Emborg, M. E. (2019) · Clinical Autonomic Research · doi:10.1007/s10286-018-00584-7 · Cited by 45 · see citing works

Gastrointestinal Dysfunction in Parkinson’s Disease: Current and Potential Therapeutics

Han, M. N., Finkelstein, D. I., McQuade, R. M., & Diwakarla, S. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020144 · Cited by 45 · see citing works

The Gastrointestinal Dysfunction Scale for Parkinson's Disease

Camacho, M., Greenland, J. C., & Williams‐Gray, C. H. (2021) · Movement Disorders · doi:10.1002/mds.28675 · Cited by 37 · see citing works

Utility of the wireless motility capsule and lactulose breath testing in the evaluation of patients with Parkinson's disease who present with functional gastrointestinal symptoms

Su, A., Gandhy, R., Barlow, C., & Triadafilopoulos, G. (2017) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2017-000132 · Cited by 36 · see citing works

Dietary Herb Extract Rikkunshi-To Ameliorates Gastroparesis in Parkinson's Disease: A Pilot Study

Doi, H., Sakakibara, R., Sato, M., Hirai, S., Masaka, T., Kishi, M., Tsuyusaki, Y., Tateno, A., Tateno, F., Takahashi, O., et al. (2014) · European Neurology · doi:10.1159/000355608 · Cited by 37 · see citing works

Gastrointestinal Dysfunction in Parkinson’s Disease: Neuro-Gastroenterology Perspectives on a Multifaceted Problem

Tan, A. H., Chuah, K. H., Beh, Y. Y., Schee, J. P., Mahadeva, S., & Lim, S. (2023) · Journal of Movement Disorders · doi:10.14802/jmd.22220 · Cited by 36 · see citing works

Pilot cohort study of endoscopic botulinum neurotoxin injection in Parkinson's disease

Triadafilopoulos, G., Gandhy, R., & Barlow, C. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.08.020 · Cited by 36 · see citing works

Gastrointestinal Dysfunction in Parkinson’s Disease

Safarpour, D., Sharzehi, K., & Pfeiffer, R. F. (2022) · Drugs · doi:10.1007/s40265-021-01664-1 · Cited by 36 · see citing works

What increases the risk of malnutrition in Parkinson's disease?

Tomić, S., Pekić, V., Popijač, Ž., Pučić, T., Petek, M., Kurić, T. G., Mišević, S., & Kramarić, R. P. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.01.070 · Cited by 32 · see citing works

Transcutaneous vagal nerve stimulation improves gastroenteric complaints in Parkinson's disease patients

Kaut, O., Janocha, L., Weismüller, T. J., & Wüllner, U. (2019) · NeuroRehabilitation · doi:10.3233/nre-192909 · Cited by 36 · see citing works

A Deep Convolutional Neural Network Approach to Classify Normal and Abnormal Gastric Slow Wave Initiation From the High Resolution Electrogastrogram

Agrusa, A. S., Gharibans, A. A., Allegra, A. B., Kunkel, D. C., & Coleman, T. P. (2019) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2019.2922235 · Cited by 29 · see citing works

Management of dysphagia and gastroparesis in Parkinson’s disease in real-world clinical practice – Balancing pharmacological and non-pharmacological approaches

Bhidayasiri, R., Phuenpathom, W., Tan, A. H., Leta, V., Phumphid, S., Chaudhuri, К. R., & Pal, P. K. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.979826 · Cited by 28 · see citing works

Reduction of gastrointestinal symptoms in Parkinson's disease after a switch from oral therapy to rotigotine transdermal patch: A non-interventional prospective multicenter trial

Woitalla, D., Kassubek, J., Timmermann, L., Lauterbach, T., Berkels, R., Grieger, F., & Müller, T. H. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.11.024 · Cited by 27 · see citing works

Therapies for Parkinson’s disease and the gut microbiome: evidence for bidirectional connection

Hey, G. E., Nair, N., Klann, E. M., Gurrala, A., Safarpour, D., Mai, V., Ramirez‐Zamora, A., & Vedam‐Mai, V. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1151850 · Cited by 27 · see citing works

Imaging Systemic Dysfunction in Parkinson’s Disease

Borghammer, P., Knudsen, K., & Brooks, D. J. (2016) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-016-0655-4 · Cited by 26 · see citing works

Parkinson’s Disease and Current Treatments for Its Gastrointestinal Neurogastromotility Effects

Ramprasad, C., Douglas, J. Y., & Moshiree, B. (2018) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-018-0201-3 · Cited by 27 · see citing works

Nizatidine ameliorates gastroparesis in Parkinson's disease: A pilot study

Doi, H., Sakakibara, R., Sato, M., Hirai, S., Masaka, T., Kishi, M., Tsuyusaki, Y., Tateno, A., Tateno, F., Takahashi, O., et al. (2013) · Movement Disorders · doi:10.1002/mds.25777 · Cited by 25 · see citing works

Early‐morning OFF and levodopa dose failures in patients with Parkinson's disease attending a routine clinical appointment using Time‐to‐ ON Questionnaire

Stocchi, F., Coletti, C., Bonassi, S., Radicati, F. G., & Vacca, L. (2018) · European Journal of Neurology · doi:10.1111/ene.13895 · Cited by 25 · see citing works

Other Forms of Gastroparesis

Quigley, E. M. M. (2014) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2014.11.006 · Cited by 24 · see citing works

Parkinson's Disease and Its Management: Part 4: Treatment of Motor Complications.

DeMaagd, G. A., & Philip, A. (2015) · PubMed Central · Cited by 23 · see citing works

Movement of prion‐like α‐synuclein along the gut–brain axis in Parkinson's disease: A potential target of curcumin treatment

Chetty, D., Abrahams, S., van Coller, R., Carr, J. A., Kenyon, C. P., & Bardien, S. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15324 · Cited by 22 · see citing works

Quantitative MRI evaluation of gastric motility in patients with Parkinson’s disease: Correlation of dyspeptic symptoms with volumetry and motility indices

Cho, J., Lee, Y. J., Kim, Y. H., Shin, C. M., Kim, J., Chang, W., & Park, J. H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216396 · Cited by 22 · see citing works

Gastro‑intestinal dysfunctions in Parkinson's disease (Review)

Ivan, I., Irincu, V. L., Diaconu, Ș., Falup‐Pecurariu, O., Ciopleiaș, B., & Falup‐Pecurariu, C. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10517 · Cited by 22 · see citing works

The Short-Term Effects and Tolerability of Low-Viscosity Soluble Fibre on Gastroparesis Patients: A Pilot Clinical Intervention Study

Suresh, H., Zhou, J., & Ho, V. (2021) · Nutrients · doi:10.3390/nu13124298 · Cited by 22 · see citing works

Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson’s disease

Lenka, A., Maria, G. D., Lamotte, G. J., Bahroo, L. B., & Jankovic, J. J. (2022) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2022.2091436 · Cited by 21 · see citing works

Management of Gastrointestinal Symptoms in Parkinson’s Disease

Pasricha, T. S., Guerrero-López, I., & Kuo, B. (2024) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001961 · Cited by 23 · see citing works

A randomized, double‐blind, placebo‐controlled trial of camicinal in Parkinson's disease

Marrinan, S. L., Otiker, T., Vasist, L., Gibson, R. A., Sarai, B. K., Barton, M. E., Richards, D. B., Hellström, P. M., Nyholm, D., Dukes, G. E., et al. (2017) · Movement Disorders · doi:10.1002/mds.27259 · Cited by 21 · see citing works

Pharmacokinetics of Inhaled Levodopa Administered With Oral Carbidopa in the Fed State in Patients With Parkinson's Disease

Safirstein, B., Ellenbogen, A. L., Zhao, P., Henney, H. R., Kegler-Ebo, D. M., & Oh, C. (2020) · Clinical Therapeutics · doi:10.1016/j.clinthera.2020.04.004 · Cited by 21 · see citing works

Upregulation of β1-adrenoceptors is involved in the formation of gastric dysmotility in the 6-hydroxydopamine rat model of Parkinson's disease

Jin, S., Zheng, L., Zhang, X., Feng, X., Fan, R., Sun, L. Z., Hong, F., Zhang, Y., & Zhu, J. (2014) · Translational research · doi:10.1016/j.trsl.2014.01.001 · Cited by 21 · see citing works

Bayesian inverse methods for spatiotemporal characterization of gastric electrical activity from cutaneous multi-electrode recordings

Allegra, A. B., Gharibans, A. A., Schamberg, G., Kunkel, D. C., & Coleman, T. P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220315 · Cited by 20 · see citing works

An Adhesive‐Integrated Stretchable Silver‐Silver Chloride Electrode Array for Unobtrusive Monitoring of Gastric Neuromuscular Activity

Kurniawan, J. F., Tjhia, B., Wu, V. M., Shin, A. J., Sit, N. L. J., Pham, T. V., Nguyen, A., Li, C., Kumar, R., Aguilar‐Rivera, M., et al. (2021) · Advanced Materials Technologies · doi:10.1002/admt.202001229 · Cited by 20 · see citing works

Neuroprotective strategies to prevent and treat Parkinson’s disease based on its pathophysiological mechanism

Lee, Y., Kim, M., & Lee, J. (2017) · Archives of Pharmacal Research · doi:10.1007/s12272-017-0960-8 · Cited by 20 · see citing works

Early low-dose ghrelin intervention via miniosmotic pumps could protect against the progressive dopaminergic neuron loss in Parkinson's disease mice

Jiao, L., Du, X., Jia, F., Li, Y., Zhu, D., Tang, T., Jiao, Q., & Jiang, H. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.01.011 · Cited by 19 · see citing works

A review of patient-specific gastrointestinal parameters as a platform for developing in vitro models for predicting the in vivo performance of oral dosage forms in patients with Parkinson’s disease

Wollmer, E., & Klein, S. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.08.126 · Cited by 19 · see citing works

Gastrointestinal Dysfunction in Chinese Patients with Parkinson’s Disease

Qin, X., Li, X., Xin, Z., & Li, Z. (2019) · Parkinson s Disease · doi:10.1155/2019/3897315 · Cited by 19 · see citing works

A technology evaluation of CVT-301 (Inbrija): an inhalable therapy for treatment of Parkinson’s disease

Lipp, M. M., Hickey, A. J., Langer, R., & LeWitt, P. A. (2021) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1960820 · Cited by 18 · see citing works

Morning Akinesia and the Potential Role of Gastroparesis – Managing Delayed Onset of First Daily Dose of Oral Levodopa in Patients with Parkinson’s Disease

Isaacson, S., & Chaudhuri, К. R. (2013) · European Neurological Review · doi:10.17925/enr.2013.08.02.82 · Cited by 17 · see citing works

Gastrointestinal dysfunction in the synucleinopathies

Chung, K. A., & Pfeiffer, R. F. (2020) · Clinical Autonomic Research · doi:10.1007/s10286-020-00745-7 · Cited by 17 · see citing works

Parkinson Disease and the Gut: A Primer for Gastroenterologists

Sharma, A., Voigt, R. M., Goetz, C. G., & Keshavarzian, A. (2025) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003508 · Cited by 16 · see citing works

Gastrointestinal Issues in Depression, Anxiety, and Neurodegenerative Diseases: A Systematic Review on Pathways and Clinical Targets Implications

Andriolo, I. R. L., Longo, B. C., de Melo, D. M., de Souza, M. M., Prediger, R. D., & da Silva, L. M. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273289138240306050532 · Cited by 14 · see citing works

Parkinson’s Disease and Diabetes Mellitus: Synergistic Effects on Pathophysiology and GI Motility

Yan, Y., Shimoga, D., & Sharma, A. (2023) · Current Gastroenterology Reports · doi:10.1007/s11894-023-00868-7 · Cited by 13 · see citing works

Olfactory function, eating ability, and visceral obesity associated with MMSE three years after Parkinson's disease diagnosis

Vikdahl, M., Domellöf, M. E., Forsgren, L., & Håglin, L. (2015) · The journal of nutrition health & aging · doi:10.1007/s12603-015-0573-1 · Cited by 13 · see citing works

Unchanged gastric emptying and visceral perception in early Parkinson's disease after a high caloric test meal

Epprecht, L., Schreglmann, S. R., Goetze, O., Woitalla, D., Baumann, C. R., & Waldvogel, D. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7799-z · Cited by 12 · see citing works

Body mass index in patients with Parkinson’s disease: a systematic review

Li, Y., Liu, Y., Du, C., & Wang, J. (2024) · Journal of Neurophysiology · doi:10.1152/jn.00363.2023 · Cited by 12 · see citing works

Lewy body diseases and the gut

Sampson, T. R., Tansey, M. G., West, A. B., & Liddle, R. A. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00804-5 · Cited by 12 · see citing works

Cohort Study in Parkinsonism

Khoshbin, K., Hassan, A., & Camilleri, M. (2020) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000001003 · Cited by 12 · see citing works

Drugs to the Rescue: Comparison of On-Demand Therapies for OFF Symptoms in Parkinson’s Disease

Martinez-Nunez, A. E., & LeWitt, P. A. (2023) · Journal of Parkinson s Disease · doi:10.3233/jpd-230055 · Cited by 11 · see citing works

A Pitx3-deficient developmental mouse model for fine motor, olfactory, and gastrointestinal symptoms of Parkinson's disease

Song, B., Feldmann, J. W., Cao, S., Feitosa, M., Kong, Y.-B., Kim, W., Schweitzer, A., Leblanc, P. R., Schweitzer, J. S., & Kim, K. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105777 · Cited by 11 · see citing works

The presence and co-incidence of geriatric syndromes in older patients with mild-moderate Lewy body dementia

Gan, J., Chen, Z., Liu, S., Shi, Z., Liu, Y., Wang, X., Liu, C., & Ji, Y. (2022) · BMC Neurology · doi:10.1186/s12883-022-02897-7 · Cited by 11 · see citing works

Levodopa/carbidopa intestinal gel (LCIG) infusion as mono- or combination therapy

Buhmann, C., Hilker, R., Lingor, P., Schrader, C., Schwarz, J., Wolz, M., & Reichmann, H. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1698-7 · Cited by 11 · see citing works

Botulinum Toxin Therapy for Nonmotor Aspects of Parkinson's Disease

Sławek, J. W., & Madalinski, M. H. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.04.012 · Cited by 10 · see citing works

Gastric-filling ultrasonography to evaluate gastric motility in patients with Parkinson's disease

Zou, X., Chen, X., Wen, Y., Jing, X., Luo, M., Xin, F.-Y., Tang, Y., Hu, M., Liu, J., & Xu, F. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1294260 · Cited by 9 · see citing works

Dopamine and Gastrointestinal Motility

Zheng, L., Liu, S., Zhou, L., Zhang, X., Xiao, Y., & Zhu, J. (2021) · Springer eBooks · doi:10.1007/978-981-33-6586-5_5 · Cited by 9 · see citing works

Gastrointestinal Motility and Response to Levodopa in Parkinson's Disease: A Proof‐of‐Concept Study

Safarpour, D., Brumbach, B. H., Arena, M., Quinn, J. F., Diamond, S. J., Nutt, J. G., & Pfeiffer, R. F. (2022) · Movement Disorders · doi:10.1002/mds.29176 · Cited by 8 · see citing works

Anesthetic Considerations for Cataract Surgery in Patients with Parkinson’s Disease: A Narrative Review

Chiew, W. A., Mathew, D., Kumar, C. M., Seet, E. C. P., Imani, F., & Khademi, S.-H. (2023) · Anesthesiology and Pain Medicine · doi:10.5812/aapm-136093 · Cited by 8 · see citing works

An Overview of Gastrointestinal Dysfunction in Parkinsonian Syndromes

Talman, L. S., & Safarpour, D. (2023) · Seminars in Neurology · doi:10.1055/s-0043-1771461 · Cited by 8 · see citing works

The Inflammatory Mechanism of Parkinson’s Disease: Gut Microbiota Metabolites Affect the Development of the Disease Through the Gut–Brain Axis

Gao, A., Lv, J., & Su, Y. (2025) · Brain Sciences · doi:10.3390/brainsci15020159 · Cited by 7 · see citing works

Esophageal and Gastric Motility Disorders in the Elderly.

Sendzischew-Shane, M. S., & Moshiree, B. (2021) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2020.08.002 · Cited by 7 · see citing works

Impact of outpatient gastroenterology consult on pharmacotherapy and management of gastrointestinal symptoms in Parkinson’s Disease

Chang, J. J., Gadi, S. R. V., Videnović, A., Kuo, B., & Pasricha, T. S. (2023) · Clinical Parkinsonism & Related Disorders · doi:10.1016/j.prdoa.2023.100215 · Cited by 7 · see citing works

131 * GASTROPARESIS SYMPTOMS IN EARLY PARKINSON'S DISEASE

Marrinan, S. L., Bajaj, N. P. S., Barker, R., Ben‐Shlomo, Y., Emmanuel, A. V., Foltynie, T., Grosset, D. G., Morris, H. R., Williams, N. M., Wood, N. W., et al. (2014) · Age and Ageing · doi:10.1093/ageing/afu047.4 · Cited by 1 · see citing works

Gastroparesis in Parkinson Disease: Pathophysiology, and Clinical Management

Soliman, H., Coffin, B., & Gourcerol, G. (2021) · Brain Sciences · doi:10.3390/brainsci11070831 · Cited by 52 · see citing works

Gastroparesis in Parkinson's disease: Diagnostic and clinical implications for optimizing pharmacological treatment

Damiens, Q., Mille, V., Faure, J., Toussirot, E., Valnet-Rabier, M., & Béreau, M. (2026) · Journal of Parkinson's Disease · doi:10.1177/1877718x261432743 · Cited by 1 · see citing works

Delayed gastric emptying in Parkinson's disease

Marrinan, S. L., Emmanuel, A. V., & Burn, D. J. (2013) · Movement Disorders · doi:10.1002/mds.25708 · Cited by 157 · see citing works

Gastric Dysfunction in Parkinson’s Disease

Rozenberg, A., Gurevich, T., Giladi, N., & Korczyn, A. D. (2012) · Humana Press eBooks · doi:10.1007/978-1-60761-429-6_9 · Cited by 3 · see citing works